The bacterial extract OM-85 BV protects mice against Influenza and Salmonella infection

International Immunopharmacology

Volumn 10, Issue 9, 2010, Pages 1086-1090

  Bessler, Wolfgang G ^a   vor dem Esche, Ulrich ^a   Masihi, Noel ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Bacterial extract; Immunoprotection; Influenza infection; OM 85 BV; Salmonella infection

Indexed keywords

BACTERIUM LYSATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; HEMAGGLUTINATION INHIBITION; INFLUENZA; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SURVIVAL; VIRUS HEMAGGLUTINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ARTHRITIS, INFECTIOUS; BACTERIA; CELL EXTRACTS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GRANULOCYTES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG DISEASES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MONOCYTES; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 77955923904     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.06.009     Document Type: Article

References (28)

1. Heintz B., Schlenter W.W., Kirsten R., Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis - a multicentric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 1989, 27:530-534.
2. Paupe J. Immunotherapy with an oral bacterial extract OM-85-BV for upper respiratory infections. Respiration 1991, 58:150-154.
3. Derenne J.P., Delclaux B. Clinical experience with OM-85 BV in upper and lower respiratory tract infections. Respiration 1992, 59:28-33.
4. Orcel B., Delclaux B., Baud M., Derenne J.P. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J 1994, 7:446-452.
5. Jara-Pérez J., Berber A. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin Ther 2000, 22:748-759.
6. Gutiérrez-Tarango M.D., Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12months. Chest 2001, 119:1742-1748.
7. Schaad U.B., Mütterlein R., Goffin H. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 2002, 122:2042-2049.
8. Collet J.P., Ducruet T., Kramer M.S., Haggerty J., Floret D., Chomel J.J., et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J 1993, 12:648-652.
9. Collet J.P., Boissel J.P. OM-85 BV: Primary versus secondary prevention. Respiration 1994, 61:20-23.
10. Wybran J., Libin M., Schandene L. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol Immunotoxicol 1989, 11:17-32.
11. Emmerich B., Emslander H.P., Milatovic D., Hallek M., Pachmann K. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis. Lung 1990, 168:726-731.
12. Nauck M., Matthys H., Emmons L.R., Perruchoud A., Reichel H., Pfleger S., et al. The immunomodulators Uro-Vaxom and Broncho-Vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidyl linositol turnover. Int J Exp Clin Chemother 1991, 4:1-11.
13. Duchow J., Marchant A., Delville J.P., Schandene L., Goldman M. Upregulation of adhesion molecules induced by Broncho-Vaxom on phagocytic cells. Int J Immunopharmacol 1992, 14:761-766.
14. Mauël J. Stimulation of immunoprotective mechanisms by OM-85 BV. Respiration 1994, 61:8-15.
15. Byl B., Libin M., Gérard M., Clumeck N., Goldman M., Mascart-Lemone F. Bacterial extract OM 85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cells. J Interferon Cytokine Res 1998, 18:817-821.
16. Keul R., Roth M., Papakonstantinou E., Nauck M., Perruchoud A.P., Block L.H. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element. Thorax 1996, 51:150-154.
17. Zelle-Rieser C., Ramoner R., Bartsch G., Thurnher M. A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells. Immunol Lett 2001, 76:63-67.
18. Bessler W.G., Huber M., Baier W. Bacterial cell wall components as immunomodulators - II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice. Int J Immunopharmacol 1997, 19:551-558.
19. Huber M., Mossmann H., Bessler W.G. Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res 2005, 10:209-217.
20. Masihi K.N., Brehmer W., Lange W., Ribi E. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Int J Immunopharmacol 1983, 5:403-410.
21. van Dijk A., Bauer J., Sedelmeier E.A., Bessler W.G. Absorption, kinetics, antibody-bound and free serum determination of a 14C-labelled Escherichia coli extract after single oral administration to rats. Arzneim-Forsch/Drug Res 1997, 47:329-334.
22. Fortier M., Bonfils A., Zalisz R., Heyman M., Smets P. Pharmacokinetic profile of RU 41740, a bacterial immunomodulator in mice, rats, and monkeys. Int J Pharm 1989, 52:27-36.
23. Endoh H., Matsunaga K., Yoshikumi C., Kawai Y., Suzuki T., Nomoto K. Production of antiserum against antitumor protein-bound polysaccharide preparation, PSK (Krestin®) and its pharmacological application. Int J Immunopharmacol 1988, 10:103-109.
24. Puigdollers J.M., Serna G.R., Hernandez del Rey I., Barruffet M.T., Torroella J.J. Immunoglobulin production in man stimulated by an orally administered bacterial lysate. Respiration 1980, 40:142-149.
25. Bowman L.M., Holt P.G. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect Immun 2001, 69:3719-3727.
26. Belyakov I.M., Ahlers J.D., Clements J.D., Strober W., Berzofsky J.A. Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL. J Immunol 2000, 165:6454-6462.
27. Sui Y., Zhu Q., Gagnon S., Dzutsev A., Terabe M., Vaccari M., et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci USA 2010, 107(21):9843-9848.
28. Masihi K.N. Immunomodulatory agents for prophylaxis and therapy of infections. Int J Antimicrob Agents 2000, 14:181-191.